Exozymes Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Exozymes Inc's ROI in the second quarter of 2026?
Exozymes Inc recorded a cumulative net loss of $-10 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -207.07%.

Within the Healthcare sector 730 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 4000 to 4223.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	-29.69 %	10.59 %	206.09 %	-	18035.15 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	6	2	4	6	8
Return On Investment (TTM)	-207.07 %	-177.63 %	-124.5 %	-90.84 %	-110.13 %
EXOZ's Overall Ranking	# 4223	# 4000	# 3613	# 0	# 0
Seq. Investment Change TTM	-9.62 %	-25.98 %	-19.87 %	31.15 %	42.17 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-10	-10	-9	-8	-8

EXOZ Company Profile >> Back to EXOZ Roi Comparisons >> See Annual EXOZ Return On Investment

Return On Investment EXOZ's Ranking
Within:	No.
Industry	# 122
Sector	# 731
Overall	# 4223

Return On Investment Statistics
High	Average	Low
-90.84 %	-155.76 %	-243.88 %
(Sep 30 2025)		(Dec 31 2024)

Financial Statements
Exozymes Inc's II. Quarter Investments	$ 6 Millions	EXOZ's Balance sheet
Exozymes Inc's II. Quarter Income	$ -3 Millions	Quarterly EXOZ's Income Statement
EXOZ's Income by Division		See EXOZ's Income by Division

EXOZ Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024
Total Investments in Millions	4	12	0	0	0
Y / Y Investment Growth	-62.36 %	-	-	-	-
Net Income in Millions	-9	-6	0	0	0
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-207.93 %	-50.09 %	-	-	-

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EXOZ's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EXOZ's Competitors
Subscribers only: Roi for Exozymes Inc's Suppliers
Subscribers only: Return On Investment for EXOZ's Customers

Other Ratios
EXOZ's Roa	EXOZ's Inventory Turnover Ratio	EXOZ's Growth Rates	EXOZ's Dividend Statistics
	EXOZ's Profitability Ratios	EXOZ's Asset Turnover Ratio	EXOZ's Dividend Growth
EXOZ's Roe	EXOZ's Valuation Ratios	EXOZ's Financial Strength Ratios	EXOZ's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-08T17:40:01+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.